BC
WST icon

Bridgefront Capital’s West Pharmaceutical WST Stock Holding History

Bridgefront Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$801K Sell
3,196
-6,152
-66% -$1.53M 0.2% 166
2025
Q4 		$2.57M Buy
+9,348
New +$2.56M 0.65% 18
2025
Q3 		– Sell
-1,423
Closed -$311K – 861
2025
Q2 		$311K Sell
1,423
-1,856
-57% -$397K 0.08% 418
2025
Q1 		$734K Buy
+3,279
New +$904K 0.21% 151
2024
Q1 		– Sell
-571
Closed -$201K – 575
2023
Q4 		$201K Sell
571
-61
-10% -$21.6K 0.15% 299
2023
Q3 		$237K Sell
632
-544
-46% -$210K 0.17% 275
2023
Q2 		$450K Buy
+1,176
New +$420K 0.24% 138
2022
Q4 		– Sell
-1,565
Closed -$385K – 537
2022
Q3 		$385K Buy
+1,565
New +$477K 0.39% 81

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return